SlideShare a Scribd company logo
PRESENTED BY:
Deepak A. Thakre
M.Pharm I Year
Industrial Pharmacy
Department
Shri Sadashivrao Patil Shikshan Sanstha's
SMT. KISHORITAI BHOYAR COLLEGE OF PHARMACY,
KAMPTEE
GUIDED BY :
Dr. Jayshree B. Taksande
HOD Pharmaceutics
Department
TOPIC : 1. The Michaelis-Menten equation &
2. Estimating Km and Vmax
1
 If metabolism is the only pathway of elimination, the rate of metabolism or elimination is defined by
the Michaelis-Menten equation.
 The (Non- linear) kinetics of capacity-limited or saturable processes is best described by Michaelis-Menten
equation:
−
𝒅𝒄
𝒅𝒕
=
𝑽𝒎𝒂𝒙𝑪
𝐊𝐦+𝐂
------- (1)
Where,
–dc/dt = rate of decline of drug concentration with time,
Vmax = theoretical maximum rate of the process,
Km = Michaelis constant,
C= drug Concentration .
 Three situations can now be considered depending upon the values of Km and C:
A] When Km = C
 Under this situation, the equation (1) reduces to i.e. −
𝑑𝑐
𝑑𝑡
=
𝑉𝑚𝑎𝑥
2
-------(2)
i.e. the rate of process is equal to one-half its maximum rate.
2
3
A plot of Michaelis-Menten equation (elimination rate dC/dt versus concentration C). Initially, the rate
increases linearly (first-order) with concentration, becomes mixed-order at higher concentration and then
reaches maximum (Vmax) beyond which it proceeds at a constant rate (zero-order).
Michaelis-Menten equation is generally used to explain the kinetics of in-vitro, few
enzyme catalyzed in-vivo and in-situ processes.
4
5
B] Km>> C
When the concentrations are low, i.e. Km> C, then Km +C is approximately
equal to Km,
−
𝒅𝒄
𝒅𝒕
=
𝐕𝐦𝐚𝐱𝐂
𝐊𝐦
------------ equation .(3)
The above equation is identical to the one that describes first-order elimination
of a drug where Vmax/Km = KE. This means that the drug concentration in the
body that results from usual dosage regimens of most drugs is well below the
Km of the elimination process with certain exceptions such as phenytoin and
alcohol.
Because both Vmax and Km are constants, the metabolism rate is proportional
to the drug concentration and is constant (i.e., first-order process).
C] C>> Km
When the concentrations are high, i.e. C > Km, then
𝒅𝒄
𝒅𝒕
=
𝑽𝒎𝒂𝒙𝑪
𝑪
= 𝑽𝒎𝒂𝒙 ------- equation (4)
Equation 4 gives the zero order kinetics.
Therefore, it was concluded that at high plasma concentrations, first order kinetics were not seen.
The above equation is identical to the one that describes a zero-order process i.e. the
rate process occurs at a constant rate Vmax and is independent of drug concentration.
 When given in therapeutic doses, most drugs produce plasma drug concentrations well below
the Km for all carrier mediated enzyme systems affecting the pharmacokinetics of the drug.
 Hence most of the drugs at normal therapeutic concentrations follow 1st order rate processes.
Some of the drugs like phenytoin and salicylate saturate the hepatic mixed function oxidases at
higher therapeutic doses.
 With these drugs, elimination kinetics is 1st order at low doses and mixed at high doses and
shows zero-order at very high therapeutic doses.
6
If a single IV bolus injection of drug D0 is given at t=0, the drug concentration, Ct in the
plasma at any time may be calculated by integrated form of Eq 1 is given by
𝑪𝒐−𝑪𝒕
𝒕
= 𝑽𝒎𝒂𝒙 −
𝑲𝒎𝑪
𝒕
𝑰𝒏
𝑪𝒐
𝒕
----equation (5)
Where C0 is the concentration at time t=0.
Alternatively the amount of the drug in the body after an IV bolus injection may be
calculated by the following relationship.
𝑫𝒐−𝑫𝒕
𝒕
= 𝑽𝒎𝒂𝒙 −
𝑲𝒎𝑪
𝒕
𝑰𝒏
𝑫𝒐
𝒕
------equation (6)
Where Do is the amount of the drug in the body at t=0.
…Equation (5)
…Equation (6)
Equation 6 can be used to study the decline of the drug in the body after the administration
of different therapeutic doses. Here, the Km and Vmax of the drug are unknown.
7
By rearranging the above Equation 6, time to decline a certain amount of the dose of a drug
can
be calculated by the following equation
𝑡 =
1
𝑉𝑚𝑎𝑥
𝐷𝑜 − 𝐷𝑡 + 𝐾𝑚 𝐼𝑛
𝐷𝑜
𝐷𝑡
-----equation (7)
Equation 7 explains an inverse relationship between the time for the dose to decline to a
certain amount of the drug in the body and Vmax.
Actually, Km can be said as the hybrid constant in enzyme kinetics that may represents both
forward as well as backward reaction.
It is equivalent to the concentration of the drug in the body at ½ Vmax.
The one compartment open model having capacity limited elimination pharmacokinetics
effectively explains the plasma drug concentration time profiles for a number of drugs.
8
9
The parameters of capacity-limited processes like metabolism, renal tubular secretion
and biliary excretion can be easily defined by assuming one-compartment kinetics for
the drug and that elimination involves only a single capacity-limited process. The
parameters Km and Vmax can be assessed from the plasma concentration-time data
collected after i.v. bolus administration of a drug with nonlinear elimination
characteristics.
Rewriting equation
−
𝒅𝒄
𝒅𝒕
=
𝑽𝒎𝒂𝒙𝑪
𝐊𝐦+𝐂
---------equation (1)
Integration of above equation followed by conversion to log base 10 yields:
𝒍𝒐𝒈𝑪 = 𝒍𝒐𝐠𝐂𝐨 +
𝐂𝐨−𝐂
𝟐.𝟑𝟎𝟑𝐊𝐦
−
𝐕𝐦𝐚𝐱
𝟐.𝟑𝟎𝟑𝐊𝐦
-------(2)
Estimating Km and Vmax
10
A semilog plot of C versus t yields a curve with a terminal linear portion having
slope –Vmax/2.303Km and when back extrapolated to time zero gives Y-
intercept log Co .The equation that describes this line is:
Fig: Semi-log plot of a drug given as i.v.
bolus with nonlinear elimination and
that fits one-compartment kinetics.
----equation (3)
11
From equation 2 and 3 ( at low Plasma Concentration)
𝐿𝑜𝑔𝐶𝑜 = 𝑙𝑜𝑔𝐶𝑜 +
𝐶𝑜−𝐶
2.303𝐾𝑚
𝑙𝑜𝑔𝐶𝑜 − 𝑙𝑜𝑔𝐶𝑜 =
𝐶𝑜−𝐶
2.203𝐾𝑚
OR
𝑙𝑜𝑔
𝐶𝑜
𝐶𝑜
=
𝐶𝑜−𝐶
2.303𝐾𝑚
For this equation Km can be obtained.
Vmax can be Computed by Substituting the value of Km in the Slope value.
Estimating Km and Vmax
Method : Equation 1 gives the relationship of the drug biotransformation to the
concentration of the drug in the body. When an experiment is performed by
using different concentrations of the drug C, a series of reaction rates (V) may
be calculated for each concentration. Km and Vmax can then be determined by
using the special plots.
Hence,
V=
𝑽𝒎𝒂𝒙𝑪
𝐊𝐦+𝐂
------ equation (8)
Rearranging the above equation 8, [As Per Equation of Slope- 𝒚 = 𝒎𝒙 + 𝒄]
1
𝑉
=
𝐾𝑚
𝑉𝑚𝑎𝑥
1
𝐶
+
1
𝑉𝑚𝑎𝑥
-----equation (9)
Above Equation 9 gives the linear equation, when 1/V is plotted against 1/C,
the resultant intercept for the line is 1/Vmax and the slope is Km/Vmax
Fig: Plot of 1/V against 1/C for the determination of Km and Vmax
12
13

More Related Content

What's hot

Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling ppt
binu anand
 
IVIVC
IVIVCIVIVC
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug delivery
SHUBHAMGWAGH
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-model
Rana Ahmed
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
PRASHANT DEORE
 
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptxIN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
RAHUL PAL
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
Malla Reddy College of Pharmacy
 
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolution
Hemanth KG
 
Protein binding interactions
Protein binding interactionsProtein binding interactions
Protein binding interactions
MehulJain143
 
Drug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal TractDrug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal Tract
Feba Elsa Mathew
 
Dissolution
DissolutionDissolution
Dissolution
Shreeshail Tumbagi
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
Hirepravin
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
Sulekha Rohilla
 
Causes of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdfCauses of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdf
Niva Rani Gogoi
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
DollySadrani
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
Dibrugarh University
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
Naveen Reddy
 
Multi compartment models
Multi compartment models Multi compartment models
Multi compartment models
SafalataJain
 
Master formula record.pdf
Master formula record.pdfMaster formula record.pdf
Master formula record.pdf
MohiniTawade
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
Malla Reddy College of Pharmacy
 

What's hot (20)

Compartment modeling ppt
Compartment modeling pptCompartment modeling ppt
Compartment modeling ppt
 
IVIVC
IVIVCIVIVC
IVIVC
 
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug delivery
 
One compartment-open-model
One compartment-open-modelOne compartment-open-model
One compartment-open-model
 
Theories of Dissolution
Theories of DissolutionTheories of Dissolution
Theories of Dissolution
 
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptxIN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
IN-VITRO-IN VIVO CORRELATION (IVIVC).pptx
 
Non linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distributionNon linear pharmacokinetics and different volumes of distribution
Non linear pharmacokinetics and different volumes of distribution
 
Compendial methods of dissolution
Compendial methods of dissolutionCompendial methods of dissolution
Compendial methods of dissolution
 
Protein binding interactions
Protein binding interactionsProtein binding interactions
Protein binding interactions
 
Drug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal TractDrug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal Tract
 
Dissolution
DissolutionDissolution
Dissolution
 
Two compartment model iv bolus muju
Two compartment model iv bolus mujuTwo compartment model iv bolus muju
Two compartment model iv bolus muju
 
Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1Two compartment open model sulekhappt.x.1
Two compartment open model sulekhappt.x.1
 
Causes of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdfCauses of non linearity in pharmacokinetics pdf
Causes of non linearity in pharmacokinetics pdf
 
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELSPHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
PHARMACOKINETICS: BASIC CONSIDERATION & PHARMACOKINETIC MODELS
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 
Multi compartment models
Multi compartment models Multi compartment models
Multi compartment models
 
Master formula record.pdf
Master formula record.pdfMaster formula record.pdf
Master formula record.pdf
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
 

Similar to Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx

Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
kavita bahmani
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdf
Kirti Goel
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
Suvarta Maru
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
Shashi Yadav
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokinetic
buner12345
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
Malla Reddy College of Pharmacy
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 
kinetics (Lec 1).pptx
kinetics (Lec 1).pptxkinetics (Lec 1).pptx
kinetics (Lec 1).pptx
HebaYassin10
 
kinetics (Lec 2).pptx
kinetics (Lec 2).pptxkinetics (Lec 2).pptx
kinetics (Lec 2).pptx
HebaYassin10
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
emebetnigatu1
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
SURYAKANTVERMA2
 
Pharmacokinetic Models
Pharmacokinetic ModelsPharmacokinetic Models
Pharmacokinetic Models
IBNSINA National Medical College
 
Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2
Areej Abu Hanieh
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
Pallavi Kurra
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
AbhinayJha3
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
AbhinayJha3
 
Compartment modeling
Compartment modelingCompartment modeling
Compartment modeling
SHILPI BISWAS
 
01_AJMS_331_21.pdf
01_AJMS_331_21.pdf01_AJMS_331_21.pdf
01_AJMS_331_21.pdf
BRNSS Publication Hub
 
Non linear pharmacokinetics.
Non linear pharmacokinetics.Non linear pharmacokinetics.
Non linear pharmacokinetics.
jatin singla
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
Divya Pushp
 

Similar to Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx (20)

Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdf
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokinetic
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
kinetics (Lec 1).pptx
kinetics (Lec 1).pptxkinetics (Lec 1).pptx
kinetics (Lec 1).pptx
 
kinetics (Lec 2).pptx
kinetics (Lec 2).pptxkinetics (Lec 2).pptx
kinetics (Lec 2).pptx
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Pharmacokinetic Models
Pharmacokinetic ModelsPharmacokinetic Models
Pharmacokinetic Models
 
Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2
 
Compartment Modelling
Compartment ModellingCompartment Modelling
Compartment Modelling
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Compartment modeling
Compartment modelingCompartment modeling
Compartment modeling
 
01_AJMS_331_21.pdf
01_AJMS_331_21.pdf01_AJMS_331_21.pdf
01_AJMS_331_21.pdf
 
Non linear pharmacokinetics.
Non linear pharmacokinetics.Non linear pharmacokinetics.
Non linear pharmacokinetics.
 
METHOD OF RESIDUALS
METHOD OF RESIDUALSMETHOD OF RESIDUALS
METHOD OF RESIDUALS
 

Recently uploaded

Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Nguyen Thanh Tu Collection
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
Celine George
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 

Recently uploaded (20)

Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
How to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRMHow to Manage Your Lost Opportunities in Odoo 17 CRM
How to Manage Your Lost Opportunities in Odoo 17 CRM
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 

Michaelis Menten Equation and Estimation Of Vmax and Tmax.pptx

  • 1. PRESENTED BY: Deepak A. Thakre M.Pharm I Year Industrial Pharmacy Department Shri Sadashivrao Patil Shikshan Sanstha's SMT. KISHORITAI BHOYAR COLLEGE OF PHARMACY, KAMPTEE GUIDED BY : Dr. Jayshree B. Taksande HOD Pharmaceutics Department TOPIC : 1. The Michaelis-Menten equation & 2. Estimating Km and Vmax 1
  • 2.  If metabolism is the only pathway of elimination, the rate of metabolism or elimination is defined by the Michaelis-Menten equation.  The (Non- linear) kinetics of capacity-limited or saturable processes is best described by Michaelis-Menten equation: − 𝒅𝒄 𝒅𝒕 = 𝑽𝒎𝒂𝒙𝑪 𝐊𝐦+𝐂 ------- (1) Where, –dc/dt = rate of decline of drug concentration with time, Vmax = theoretical maximum rate of the process, Km = Michaelis constant, C= drug Concentration .  Three situations can now be considered depending upon the values of Km and C: A] When Km = C  Under this situation, the equation (1) reduces to i.e. − 𝑑𝑐 𝑑𝑡 = 𝑉𝑚𝑎𝑥 2 -------(2) i.e. the rate of process is equal to one-half its maximum rate. 2
  • 3. 3 A plot of Michaelis-Menten equation (elimination rate dC/dt versus concentration C). Initially, the rate increases linearly (first-order) with concentration, becomes mixed-order at higher concentration and then reaches maximum (Vmax) beyond which it proceeds at a constant rate (zero-order).
  • 4. Michaelis-Menten equation is generally used to explain the kinetics of in-vitro, few enzyme catalyzed in-vivo and in-situ processes. 4
  • 5. 5 B] Km>> C When the concentrations are low, i.e. Km> C, then Km +C is approximately equal to Km, − 𝒅𝒄 𝒅𝒕 = 𝐕𝐦𝐚𝐱𝐂 𝐊𝐦 ------------ equation .(3) The above equation is identical to the one that describes first-order elimination of a drug where Vmax/Km = KE. This means that the drug concentration in the body that results from usual dosage regimens of most drugs is well below the Km of the elimination process with certain exceptions such as phenytoin and alcohol. Because both Vmax and Km are constants, the metabolism rate is proportional to the drug concentration and is constant (i.e., first-order process).
  • 6. C] C>> Km When the concentrations are high, i.e. C > Km, then 𝒅𝒄 𝒅𝒕 = 𝑽𝒎𝒂𝒙𝑪 𝑪 = 𝑽𝒎𝒂𝒙 ------- equation (4) Equation 4 gives the zero order kinetics. Therefore, it was concluded that at high plasma concentrations, first order kinetics were not seen. The above equation is identical to the one that describes a zero-order process i.e. the rate process occurs at a constant rate Vmax and is independent of drug concentration.  When given in therapeutic doses, most drugs produce plasma drug concentrations well below the Km for all carrier mediated enzyme systems affecting the pharmacokinetics of the drug.  Hence most of the drugs at normal therapeutic concentrations follow 1st order rate processes. Some of the drugs like phenytoin and salicylate saturate the hepatic mixed function oxidases at higher therapeutic doses.  With these drugs, elimination kinetics is 1st order at low doses and mixed at high doses and shows zero-order at very high therapeutic doses. 6
  • 7. If a single IV bolus injection of drug D0 is given at t=0, the drug concentration, Ct in the plasma at any time may be calculated by integrated form of Eq 1 is given by 𝑪𝒐−𝑪𝒕 𝒕 = 𝑽𝒎𝒂𝒙 − 𝑲𝒎𝑪 𝒕 𝑰𝒏 𝑪𝒐 𝒕 ----equation (5) Where C0 is the concentration at time t=0. Alternatively the amount of the drug in the body after an IV bolus injection may be calculated by the following relationship. 𝑫𝒐−𝑫𝒕 𝒕 = 𝑽𝒎𝒂𝒙 − 𝑲𝒎𝑪 𝒕 𝑰𝒏 𝑫𝒐 𝒕 ------equation (6) Where Do is the amount of the drug in the body at t=0. …Equation (5) …Equation (6) Equation 6 can be used to study the decline of the drug in the body after the administration of different therapeutic doses. Here, the Km and Vmax of the drug are unknown. 7
  • 8. By rearranging the above Equation 6, time to decline a certain amount of the dose of a drug can be calculated by the following equation 𝑡 = 1 𝑉𝑚𝑎𝑥 𝐷𝑜 − 𝐷𝑡 + 𝐾𝑚 𝐼𝑛 𝐷𝑜 𝐷𝑡 -----equation (7) Equation 7 explains an inverse relationship between the time for the dose to decline to a certain amount of the drug in the body and Vmax. Actually, Km can be said as the hybrid constant in enzyme kinetics that may represents both forward as well as backward reaction. It is equivalent to the concentration of the drug in the body at ½ Vmax. The one compartment open model having capacity limited elimination pharmacokinetics effectively explains the plasma drug concentration time profiles for a number of drugs. 8
  • 9. 9 The parameters of capacity-limited processes like metabolism, renal tubular secretion and biliary excretion can be easily defined by assuming one-compartment kinetics for the drug and that elimination involves only a single capacity-limited process. The parameters Km and Vmax can be assessed from the plasma concentration-time data collected after i.v. bolus administration of a drug with nonlinear elimination characteristics. Rewriting equation − 𝒅𝒄 𝒅𝒕 = 𝑽𝒎𝒂𝒙𝑪 𝐊𝐦+𝐂 ---------equation (1) Integration of above equation followed by conversion to log base 10 yields: 𝒍𝒐𝒈𝑪 = 𝒍𝒐𝐠𝐂𝐨 + 𝐂𝐨−𝐂 𝟐.𝟑𝟎𝟑𝐊𝐦 − 𝐕𝐦𝐚𝐱 𝟐.𝟑𝟎𝟑𝐊𝐦 -------(2) Estimating Km and Vmax
  • 10. 10 A semilog plot of C versus t yields a curve with a terminal linear portion having slope –Vmax/2.303Km and when back extrapolated to time zero gives Y- intercept log Co .The equation that describes this line is: Fig: Semi-log plot of a drug given as i.v. bolus with nonlinear elimination and that fits one-compartment kinetics. ----equation (3)
  • 11. 11 From equation 2 and 3 ( at low Plasma Concentration) 𝐿𝑜𝑔𝐶𝑜 = 𝑙𝑜𝑔𝐶𝑜 + 𝐶𝑜−𝐶 2.303𝐾𝑚 𝑙𝑜𝑔𝐶𝑜 − 𝑙𝑜𝑔𝐶𝑜 = 𝐶𝑜−𝐶 2.203𝐾𝑚 OR 𝑙𝑜𝑔 𝐶𝑜 𝐶𝑜 = 𝐶𝑜−𝐶 2.303𝐾𝑚 For this equation Km can be obtained. Vmax can be Computed by Substituting the value of Km in the Slope value.
  • 12. Estimating Km and Vmax Method : Equation 1 gives the relationship of the drug biotransformation to the concentration of the drug in the body. When an experiment is performed by using different concentrations of the drug C, a series of reaction rates (V) may be calculated for each concentration. Km and Vmax can then be determined by using the special plots. Hence, V= 𝑽𝒎𝒂𝒙𝑪 𝐊𝐦+𝐂 ------ equation (8) Rearranging the above equation 8, [As Per Equation of Slope- 𝒚 = 𝒎𝒙 + 𝒄] 1 𝑉 = 𝐾𝑚 𝑉𝑚𝑎𝑥 1 𝐶 + 1 𝑉𝑚𝑎𝑥 -----equation (9) Above Equation 9 gives the linear equation, when 1/V is plotted against 1/C, the resultant intercept for the line is 1/Vmax and the slope is Km/Vmax Fig: Plot of 1/V against 1/C for the determination of Km and Vmax 12
  • 13. 13